|国家科技期刊平台
首页|期刊导航|医药导报|《精神疾病治疗药物的术前管理:围手术期评估和质量改善协会共识声明》解读

《精神疾病治疗药物的术前管理:围手术期评估和质量改善协会共识声明》解读OA北大核心CSTPCD

Interpretation of Preoperative Management of Medications for Psychiatric Diseases:Society for Perioperative Assessment and Quality Improvement Consensus Statement

中文摘要英文摘要

手术前精神疾病治疗药物管理相关指南的缺乏,会影响精神病患者的手术管理质量,增加围手术期并发症出现的概率.为规范精神疾病治疗药物手术前管理,围手术期评估和质量改善协会于 2022 年 2 月颁布了《精神疾病治疗药物的术前管理:围手术期评估和质量改善协会共识声明》,为临床医生提供手术前精神药物管理的建议.该文对该共识进行解读,总结抗抑郁药、心境稳定剂、抗焦虑药、抗精神病药和注意力缺陷多动障碍药物的围手术期与麻醉药物相互作用、特殊注意事项和辅助检查注意事项,并提供相应的手术前建议,以期为围手术期药物的规范化管理提供参考.

The lack of preoperative guidelines for the management of drugs for psychiatric disorders will affect the quality of surgical management of psychiatric patients and increase the probability of perioperative complications.To standardize the preoperative management of medications for the treatment of mental disorders,the Perioperative Assessment and Quality Improvement Society issued《Preoperative Management of Medications for Psychiatric Diseases:Society for Perioperative Assessment and Quality Improvement Consensus Statement》in February 2022 to provide clinicians with recommendations for the preoperative management of psychotropic medications.This article interpreted the consensus,summarized the perioperative interactions,special precautions,and auxiliary examination precautions,and provided corresponding preoperative suggestions on antidepressants,mood stabilizers,anxiety,antipsychotics,and attention deficit hyperactivity disorder drugs,to provide a reference for the standardized management of perioperative drugs.

谢菡;马旭东;葛卫红;张海霞;盛梦迪

南京大学医学院附属鼓楼医院药学部,南京 210008中国药科大学南京鼓楼医院药学部,南京 210008||中国药科大学基础医学与临床药学学院,南京 210009南京大学医学院附属鼓楼医院药学部,南京 210008||中国药科大学南京鼓楼医院药学部,南京 210008

药学

精神疾病治疗药物围手术期药物管理指南解读

Medication for mental disordersPerioperative drug managementInterpretation of guidelines

《医药导报》 2024 (007)

1038-1045 / 8

南京大学现代医院管理与发展研究所课题(NDYG2021044);奥赛康医院药学基金科研课题(A202108).

10.3870/j.issn.1004-0781.2024.07.002

评论